Clinical Trials Logo

Sleep Apnea, Obstructive clinical trials

View clinical trials related to Sleep Apnea, Obstructive.

Filter by:

NCT ID: NCT01187160 Completed - Clinical trials for Obstructive Sleep Apnea

Transoral Robotic Surgery (TORS) for Sleep Apnea

Start date: October 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to assess if the da Vinci® Robotic Surgical System (Intuitive Surgical, Inc., Sunnyvale, CA) allows for "adequate exposure" for transoral resection of hypertrophic lingual tonsils in patients with obstructive sleep apnea.

NCT ID: NCT01186926 Completed - Clinical trials for Obstructive Sleep Apnea

Australian Clinical Study of the Apnex Medical HGNS System to Treat Obstructive Sleep Apnea

Start date: March 2009
Phase: Phase 2/Phase 3
Study type: Interventional

The overall goal of the study is to evaluate the safety, efficacy and therapy settings of the HGNS System for stimulating the hypoglossal nerve to help maintain an open airway in subjects with obstructive sleep apnea (OSA).

NCT ID: NCT01184118 Completed - Lung Disease Clinical Trials

DREAM: Does Inhaled Fluticasone REsult in Obstructive Sleep Apnea Manifestations?

DREAM
Start date: March 2009
Phase: N/A
Study type: Interventional

This study is being conducted to find out if the use of inhaled corticosteroids has an affect on upper airway collapsibility and sleep apnea risk. An inhaled corticosteroid is a common asthma controller medication like Flovent. Sleep apnea is w hen someone stops breathing for a short period of time during sleep. For some reason, people with asthma have more sleep apnea and upper airway collapsibility (weakness) than the general population. There are many possible reasons for this and one might be related to the use of inhaled corticosteroids. The overall hypothesis of this study is to determine whether inhaled fluticasone propionate (FP) increases UAW collapsibility and to assess tongue (genioglossus muscle) dysfunction as a potential underlying mechanism.

NCT ID: NCT01181570 Completed - Psoriasis Clinical Trials

Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea

Start date: September 2010
Phase: Phase 4
Study type: Interventional

This study will evaluate the effect and safety of adalimumab in approximately 20 subjects with mild to moderate psoriasis and sleep apnea and will be conducted in one treatment center located in Montreal. Patients with psoriasis often have additional disorders such as obesity. Obese patients are more at risk of developing obstructive sleep apnea. This is believed to be caused by both the collapse of upper airways and inflammation (swelling). Adalimumab, a drug currently approved by Health Canada for the treatment of psoriasis, blocks tumor necrosis factor-alpha (TNF-alpha). This chemical is present at higher levels in patients with sleep apnea. It is believed that adalimumab could improve obstructive sleep apnea by lowering the levels of TNF-alpha.

NCT ID: NCT01175421 Completed - Sleep Apnea Clinical Trials

Multidimensional System as Predictor of Outcomes in Obstructive Sleep Apnea: The OSA-SCORE

OSA-SCORE
Start date: May 2010
Phase: N/A
Study type: Observational

Purpose: In a retrospective cohort the investigators will validate, the goodness of a multidimensional index to classified the severity of patients with sleep disordered breathing that has been previously developed in a prospective longitudinal cohort.

NCT ID: NCT01175031 Completed - Clinical trials for Obstructive Sleep Apnea

Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography

Start date: September 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate diagnostic agreement and determine the accuracy of the continuous positive airway pressure (CPAP) device compared to simultaneous, attended clinical polysomnography (PSG) in identifying breathing events in participants previously diagnosed with complex sleep apnea (CompSAS), complex sleep apnea with Cheyne-Stokes respiration (CSR), or obstructive sleep apnea (OSA).

NCT ID: NCT01173432 Completed - Metabolic Syndrome Clinical Trials

Exploring the Role of Adipocyte Fatty Acid Binding Protein in the Association of Obstructive Sleep Apnea and Metabolic Dysfunction

Start date: June 2008
Phase: N/A
Study type: Interventional

Adipocyte fatty acid binding protein (A-FABP) is a member of the FABP super family, is abundant in adipocytes and macrophages. Regulatory functions of A-FABP in lipid and glucose metabolism have been described, and it is suggested to play an important role in the pathogenesis of metabolic syndrome.We hypothesize that obstructive sleep apnea (OSA) may upregulate A-FABP production and thus causally contribute to metabolic dysfunction. Our group has recently demonstrated that A-FABP, expressed and secreted from adipocytes, is present in the blood stream .The levels of A-FABP correlated with various metabolic variates in the metabolic syndrome. Furthermore, we have obtained novel data in men with a range of sleep disordered breathing showed that the duration of oxygen desaturation correlated with circulating levels of A-FABP, independent of age and waist/body mass index. The current proposal aims to pursue this finding and further explore the role of A-FABP in the association of OSA and metabolic dysfunction.

NCT ID: NCT01173406 Completed - Clinical trials for Obstructive Sleep Apnea

Education Programme on Continuous Positive Airway Pressure Treatment

Start date: May 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to examine whether an education programme would enhance continuous positive airway pressure (CPAP) adherence.

NCT ID: NCT01172093 Completed - Diabetes Mellitus Clinical Trials

A Study on the Prevalence of Obstructive Sleep Apnea in Patients With Type II Diabetes Mellitus

Start date: January 2007
Phase: N/A
Study type: Observational

OSA is prevalent among patients with type II DM

NCT ID: NCT01171196 Completed - Clinical trials for Obstructive Sleep Apnea

Questionnaires to Identify Chinese Patients at Risk for Obstructive Sleep Apnea

Start date: July 2010
Phase: N/A
Study type: Observational

The purpose of this study is to validate the Berlin questionnaire and STOP-BANG (snore, tired, obstruction, pressure, body mass index (BMI), age, neck, gender) as effective screening tools for Chinese subjects who are suspected to have obstructive sleep apnea (OSA).